Imodium (Loperamide hydrochloride) Capsules

Brand Origin and History

Imodium is a globally recognized pharmaceutical brand, originally developed by Paul Janssen at Janssen Pharmaceutica in Beerse, Belgium. The active ingredient, loperamide hydrochloride, was discovered in 1969 and has since become a standard treatment for the relief of diarrhea. The packaging in the image shows text in Bulgarian, indicating its distribution within the Balkan market.

Manufacturing and Distribution

Imodium is manufactured in multiple locations worldwide to meet international demand. Key production sites are historically located in France and Italy, although specific regional batches like this one are distributed by local healthcare entities such as Johnson & Johnson Consumer Inc.

Ownership and Global Presence

In the mid-2000s, Johnson & Johnson acquired the Pfizer consumer healthcare division and solidified its control over major consumer health brands including Imodium. In 2023, Johnson & Johnson spun off its consumer health division into a new, independent publicly traded company called Kenvue. As of 2024 and beyond, Kenvue is the ultimate owner of the Imodium brand, headquarted in the United States, and continues to manage its global marketing and distribution.